Bedel Financial Consulting, Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bedel Financial Consulting, Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,0000.0%380.0%0.00%
Q3 2021$1,000
-50.0%
380.0%0.00%
-100.0%
Q2 2021$2,0000.0%380.0%0.00%0.0%
Q1 2021$2,0000.0%380.0%0.00%0.0%
Q4 2020$2,0000.0%380.0%0.00%0.0%
Q3 2020$2,0000.0%380.0%0.00%0.0%
Q2 2020$2,000
-71.4%
38
-72.5%
0.00%
-80.0%
Q1 2020$7,000
+250.0%
138
+263.2%
0.01%
+400.0%
Q4 2019$2,0000.0%380.0%0.00%0.0%
Q3 2019$2,000380.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders